From Tech Transfer to Trials
Unable to add items
Add to basket failed.
Add to wishlist failed.
Failed to remove from Wish List.
Adding to library failed
Unable to follow podcast
Unable to unfollow podcast
From Tech Transfer to Trials
-
Narrated by:
-
By:
In this episode of PatientPod, George Kramb sits down with David Craig, CEO and co-founder of Sarcomatrix, to talk about what it really takes to build in biotech, advance therapies in muscular dystrophy, and navigate the gap between scientific innovation and real-world execution.
Here's exactly what you'll learn:
✔️ Why progress in complex diseases often comes from incremental gains and combination therapies, not single breakthroughs
✔️ What the current reality of gene editing and CRISPR looks like beyond the hype
✔️ How early-stage biotech teams can align clinical, commercial, and operational strategy from the start
✔️ A practical path for aspiring founders, from building technical depth to developing real business execution
Hosted on Acast. See acast.com/privacy for more information.
